Patients want to do more with mobile and see doctors less. Two studies outline the types of digital interventions patients are interested in.
The move to digitize a series of books it co-created with Disney for kids with type 1 diabetes was spurred by a meeting with the online diabetes community.
Re-Mission, the video simulation known to change young patients' attitudes toward cancer, is in its second iteration. And one big drug maker has added its backing.
Remedy Health is hoping a new design for its flagship portal can give it an edge over rivals WebMD and Everyday Health.
Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.
The drug maker's broadcast-heavy "OAB reality" campaign stresses the emotional toll on women.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
Sanofi named Connect & Coach as the winner of its 2013 Data Design Diabetes contest
Pharmas need to start fine-tuning paid search and producing "liquid content" that moves fluidly between screens, said Google's David Blair at our first MM&M Skill Sets Live session
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.
Doctors call out Novartis on drug prices; Aubagio shows strong top-line data in trials; and overseas docs increasingly turn to digital.
Sanofi Pasteur scored a pharma first this past winter by offering "Shazam" technology as a way for viewers to interact with TV commercials for its Fluzone Intradermal influenza vaccine—and to find out where they could get the new shot.
WorldOne will use a $35 million financing windfall for a global build-out of the physician social network it acquired in July.
Gwee, who pioneered pharma social media at Vertex before moving onto the agency side, is tasked with integrating digital and social strategies across the marketing and PR network's 14 agencies.
Google's latest YouTube update aims to make its Channels more social, and even as the company has given its pharma clients an extra month to hold on to their old page designs, the new format is inspiring anxiety among drug firms and medical agencies.
Remedy Health Media is partnering with the University of California-Berkeley on BerkeleyWellness.com, which will deliver wellness information to consumers with the customary interactive spoonfuls of sugar—quizzes, slideshows, email alerts and social media feeds, along with roundtables and video chats featuring Berkeley experts.
Taking a page from Sanofi, Shire is preparing to launch a developer challenge "to create technology driven solutions that aid individuals with ADHD during the transition from adolescence into adulthood."
What changes in marketing or audience viewing habits might impact pharma's media investment this year? Media buyers weigh in on the hot channel trends.
From FDA and pharma, to Caronia and off-label communication, three healthcare policy experts offer their take on what 2013 holds in store.
MDLinx owner M3 Group is partnering with Argentine online CME firm Medcenter on a content-sharing deal that will expand its in-language reach to Spain, Portugal and Latin America.
Biogen Idec sets aside $10M for ALS research, HHS clears eight exchanges.
A new campaign from J&J's DePuy Orthopedics, aimed at raising awareness of joint replacement, features Baby Boomers' letters to their younger selves.
Pfizer has the strongest social media presence of any pharma, a WEGO Health/Digital Health Coalition poll suggests.
Adrian Sansone is taking over the managing director's seat at Publicis Lifebrands Medicus, and is tasked with changing the way the HCP agency operates.
Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.
Publicis is uniting two of its digital agencies as it seeks to keep the pure-play "e" units competitive.
A new video-based educational series will aim to tailor content to both patients and physicians, the firms behind the effort say.
WebMD had to go all the way up to 42nd Street to find its new CEO, Pfizer honcho Cavan Redmond. He brings a keen understanding of the site's biopharma industry advertisers, and he'll need it as the portal looks to shore up flagging ad sales on the consumer side of its business
Physician social network adoption was flat from 2011-2012, a survey says, and Everyday Health gets a nom for a daytime Emmy
Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers - whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.
*Group discounts available on request
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.